AU613262B2 - Viricidal blood bag system - Google Patents
Viricidal blood bag system Download PDFInfo
- Publication number
- AU613262B2 AU613262B2 AU49389/90A AU4938990A AU613262B2 AU 613262 B2 AU613262 B2 AU 613262B2 AU 49389/90 A AU49389/90 A AU 49389/90A AU 4938990 A AU4938990 A AU 4938990A AU 613262 B2 AU613262 B2 AU 613262B2
- Authority
- AU
- Australia
- Prior art keywords
- bag
- blood
- viricidal
- substance
- container
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 210000004369 blood Anatomy 0.000 title claims abstract description 47
- 239000008280 blood Substances 0.000 title claims abstract description 47
- 230000003253 viricidal effect Effects 0.000 title claims abstract description 37
- 239000000126 substance Substances 0.000 claims abstract description 24
- 239000012503 blood component Substances 0.000 claims abstract description 22
- 241000700605 Viruses Species 0.000 claims abstract description 14
- 229920003023 plastic Polymers 0.000 claims abstract description 11
- 238000011065 in-situ storage Methods 0.000 claims abstract description 10
- 230000000415 inactivating effect Effects 0.000 claims abstract description 3
- 239000000243 solution Substances 0.000 claims description 20
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 13
- 238000004891 communication Methods 0.000 claims description 12
- UKLNMMHNWFDKNT-UHFFFAOYSA-M sodium chlorite Chemical compound [Na+].[O-]Cl=O UKLNMMHNWFDKNT-UHFFFAOYSA-M 0.000 claims description 9
- 229960002218 sodium chlorite Drugs 0.000 claims description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 8
- 230000002779 inactivation Effects 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 7
- 239000006172 buffering agent Substances 0.000 claims description 4
- 239000003153 chemical reaction reagent Substances 0.000 claims description 2
- 230000003612 virological effect Effects 0.000 claims description 2
- 239000000644 isotonic solution Substances 0.000 claims 1
- OSVXSBDYLRYLIG-UHFFFAOYSA-N chlorine dioxide Inorganic materials O=Cl=O OSVXSBDYLRYLIG-UHFFFAOYSA-N 0.000 abstract description 30
- 235000019398 chlorine dioxide Nutrition 0.000 abstract description 15
- QBWCMBCROVPCKQ-UHFFFAOYSA-N chlorous acid Chemical compound OCl=O QBWCMBCROVPCKQ-UHFFFAOYSA-N 0.000 abstract description 3
- 239000000306 component Substances 0.000 abstract description 2
- 239000004155 Chlorine dioxide Substances 0.000 description 14
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 210000003743 erythrocyte Anatomy 0.000 description 6
- 239000000047 product Substances 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 239000004599 antimicrobial Substances 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000004310 lactic acid Substances 0.000 description 4
- 235000014655 lactic acid Nutrition 0.000 description 4
- 102000009027 Albumins Human genes 0.000 description 3
- 108010088751 Albumins Proteins 0.000 description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 230000002147 killing effect Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229920000915 polyvinyl chloride Polymers 0.000 description 3
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- 241000700588 Human alphaherpesvirus 1 Species 0.000 description 2
- 241000725303 Human immunodeficiency virus Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 210000001772 blood platelet Anatomy 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 229940077239 chlorous acid Drugs 0.000 description 2
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 2
- 230000001627 detrimental effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000035899 viability Effects 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 1
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- XTEGARKTQYYJKE-UHFFFAOYSA-M Chlorate Chemical compound [O-]Cl(=O)=O XTEGARKTQYYJKE-UHFFFAOYSA-M 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 229920012485 Plasticized Polyvinyl chloride Polymers 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 239000003114 blood coagulation factor Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000012928 buffer substance Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940005989 chlorate ion Drugs 0.000 description 1
- 229960003405 ciprofloxacin Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000007323 disproportionation reaction Methods 0.000 description 1
- 230000000531 effect on virus Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011012 sanitization Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/02—Blood transfusion apparatus
- A61M1/0209—Multiple bag systems for separating or storing blood components
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
- A61L2/0094—Gaseous substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/20—Gaseous substances, e.g. vapours
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/02—Blood transfusion apparatus
- A61M1/0209—Multiple bag systems for separating or storing blood components
- A61M1/0218—Multiple bag systems for separating or storing blood components with filters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3687—Chemical treatment
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Anesthesiology (AREA)
- General Chemical & Material Sciences (AREA)
- External Artificial Organs (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US309445 | 1989-02-10 | ||
| US07/309,445 US5240829A (en) | 1989-02-10 | 1989-02-10 | Method for inactivating viruses in blood using chlorine dioxide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU4938990A AU4938990A (en) | 1990-08-16 |
| AU613262B2 true AU613262B2 (en) | 1991-07-25 |
Family
ID=23198265
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU49389/90A Ceased AU613262B2 (en) | 1989-02-10 | 1990-02-09 | Viricidal blood bag system |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5240829A (OSRAM) |
| EP (1) | EP0382018B1 (OSRAM) |
| JP (1) | JPH02274253A (OSRAM) |
| AT (1) | ATE82845T1 (OSRAM) |
| AU (1) | AU613262B2 (OSRAM) |
| CA (1) | CA1336423C (OSRAM) |
| DE (1) | DE69000503T2 (OSRAM) |
| DK (1) | DK0382018T3 (OSRAM) |
| ES (1) | ES2054113T3 (OSRAM) |
| GR (1) | GR3006451T3 (OSRAM) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5425925A (en) * | 1990-04-19 | 1995-06-20 | Winfield Industries, Inc. | Multi-stage infectious waste treatment system |
| US5656248A (en) * | 1990-04-19 | 1997-08-12 | Winfield Industries Inc. | Multi-stage infectious waste treatment system |
| US5190725A (en) * | 1990-04-19 | 1993-03-02 | Winfield Industries | Chemical treatment of an infectious waste |
| EP0455326A3 (en) * | 1990-04-19 | 1993-01-07 | Winfield Corporation | Bag with disinfectant for sterilizing infectious waste |
| DE9102709U1 (de) * | 1991-03-07 | 1991-05-23 | Blutspendedienst der Landesverbände des Deutschen Roten Kreuzes Niedersachsen, Oldenburg und Bremen Gemeinnützige GmbH, 3257 Springe | Blutbeutelanordnung |
| US6207107B1 (en) | 1992-10-05 | 2001-03-27 | Baxter International Inc. | Steam sterilizable system for inactivating viral contaminants in body fluids |
| JPH06183998A (ja) | 1992-10-23 | 1994-07-05 | Hirohide Miwa | 体液関連疾患治療方法及びその装置と使用薬剤 |
| WO1995000631A1 (en) * | 1993-06-23 | 1995-01-05 | New York Blood Center, Inc. | System for viral inactivation of blood |
| US5591350A (en) * | 1994-04-15 | 1997-01-07 | Pall Corporation | Iodine disinfection method using a gaseous iodine treated porous medium |
| JP3492423B2 (ja) * | 1994-07-19 | 2004-02-03 | 佐内 藤田 | 医療廃棄物の殺菌脱臭方法及び装置 |
| US7666384B2 (en) * | 2008-01-17 | 2010-02-23 | Sanderson William D | Stable chlorine dioxide tablet |
| US9211354B2 (en) * | 2011-09-28 | 2015-12-15 | American Sterilizer Company | Bulkhead assembly for VHP unit with removable diffuser |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4504442A (en) * | 1982-10-19 | 1985-03-12 | Scopas Technology Corporation | Use of chlorine dioxide gas as a chemosterilizing agent |
| US4908188A (en) * | 1985-02-05 | 1990-03-13 | The Scopas Technology Company, Inc. | Gas sterilant system |
| US4971760A (en) * | 1986-03-10 | 1990-11-20 | University Of Southern California | Novel method for disinfecting red blood cells, blood platelets, blood plasma, and optical corneas and sclerae |
| AU7281487A (en) * | 1986-04-07 | 1987-11-09 | Habib Al-Sioufi | Anti-pathogenic blood collection system and method |
| EP0315627B1 (en) * | 1986-08-01 | 1992-08-19 | RUBINSTEIN, Alan I. | A method to treat blood |
-
1989
- 1989-02-10 US US07/309,445 patent/US5240829A/en not_active Expired - Fee Related
- 1989-09-29 CA CA000614491A patent/CA1336423C/en not_active Expired - Fee Related
-
1990
- 1990-01-26 DK DK90101561.0T patent/DK0382018T3/da active
- 1990-01-26 EP EP90101561A patent/EP0382018B1/en not_active Expired - Lifetime
- 1990-01-26 AT AT90101561T patent/ATE82845T1/de not_active IP Right Cessation
- 1990-01-26 DE DE9090101561T patent/DE69000503T2/de not_active Expired - Fee Related
- 1990-01-26 ES ES90101561T patent/ES2054113T3/es not_active Expired - Lifetime
- 1990-02-08 JP JP2027314A patent/JPH02274253A/ja active Pending
- 1990-02-09 AU AU49389/90A patent/AU613262B2/en not_active Ceased
-
1992
- 1992-12-03 GR GR920402582T patent/GR3006451T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69000503T2 (de) | 1993-04-08 |
| AU4938990A (en) | 1990-08-16 |
| GR3006451T3 (OSRAM) | 1993-06-21 |
| DK0382018T3 (da) | 1993-03-08 |
| DE69000503D1 (de) | 1993-01-14 |
| ATE82845T1 (de) | 1992-12-15 |
| US5240829A (en) | 1993-08-31 |
| EP0382018A3 (en) | 1990-09-12 |
| EP0382018B1 (en) | 1992-12-02 |
| ES2054113T3 (es) | 1994-08-01 |
| CA1336423C (en) | 1995-07-25 |
| EP0382018A2 (en) | 1990-08-16 |
| JPH02274253A (ja) | 1990-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU613262B2 (en) | Viricidal blood bag system | |
| US5281392A (en) | Method for disinfecting red blood cells, blood products, and corneas | |
| US5185371A (en) | Method for disinfecting red blood cells | |
| Yoshida et al. | Extended storage of red blood cells under anaerobic conditions | |
| FI86253C (fi) | Syntetiskt, plasmafritt, transfusibelt foervaringsmedium foer blodplaettar. | |
| US5019402A (en) | Composition and procedure for disinfecting blood and blood components | |
| US8968992B2 (en) | Red blood cell storage medium for extended storage | |
| CN109195632A (zh) | 厌氧血液储存和病原体失活方法 | |
| US5709992A (en) | Method for disinfecting red blood cells | |
| EP0559856A1 (en) | Antimicrobial preservation of platelets and blood factors | |
| EP1448052B1 (en) | Anti-pathogenic composition useful in blood preservation | |
| Snyder et al. | Reducing the risk of blood transfusion | |
| SK287562B6 (sk) | Spôsob potlačenia rastu baktérií a redukcie glykolýzy v celej krvi alebo jej frakcii | |
| JPH04501069A (ja) | 血液成分、角膜、及び鞏膜組織の殺菌 | |
| EP1244353B1 (en) | Compositions for the storage of platelets | |
| US9315775B2 (en) | Methods and materials for prolonging useful storage of red blood cell preparations and platelet preparations | |
| AU648823B2 (en) | Antimicrobial preservation of plasma | |
| CA2091712C (en) | Use of a chemically-stabilised chlorite matrix for the parenteral treatment of hiv infections | |
| EP0614368A4 (en) | SAFE BLOOD FOR HUMAN TRANSFUSION. | |
| Burch et al. | Alterations in glutathione during storage of human platelet concentrates | |
| US20130143196A1 (en) | Methods and materials for prolonging useful storage of red blood cell preparations and platelet preparations | |
| EP0435944A1 (en) | Water purifying system | |
| WO2002023988A1 (en) | Prolonged storage of red blood cells | |
| WO1993004731A1 (en) | Iodine-iodide treatment of red blood cells | |
| Lozano et al. | In vitro analysis of platelet concentrates stored in the presence of modulators of 3′, 5′ adenosine monophosphate, and organic anions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |